ETS2 and breast neoplasm: Conditional ablation of Ets2 in TAMs results in decreased angiogenesis and reduced growth of mouse mammary tumors, as well as the reduced frequency and size of lung metastases, suggesting that Ets2 serves as the driver for a transcriptional program that promotes angiogenesis of breast tumors [98].